School of Medicine, Universidad Sanitas, Bogotá D.C, 110111, Colombia.
Clínica Universitaria Colombia, Bogotá D.C, 110111, Colombia.
BMC Surg. 2023 Jan 26;23(1):19. doi: 10.1186/s12893-023-01901-2.
Radical gastrectomy has traditionally been the pillar treatment with curative intent for malignant tumors of the stomach. The safety of the laparoscopic approach for advanced gastric cancer (AGC) is still under debate. In our institution, laparoscopic gastrectomy is the most performed approach.
Our aim is to describe the experience of a high-volume center in the treatment of AGC in Colombia and to analyze the short-term results and the overall survival rate at 1, 3, and 5 years comparing the open and laparoscopic approaches.
A cross-sectional retrospective study of patients who underwent gastrectomy for advanced gastric cancer by open or laparoscopic approaches were performed. A Will-Coxon Mann Whitney test was performed in terms of lymph node status and surgical approach. Survival analysis was performed using the Kaplan-Meier method for overall survival at 1, 3, and 5 years. An initial log-rank test was performed to test the relationships between the operative variables and overall survival, the statistical value was accepted if p < 0.20. Data with an initial statistical relationship in the log-rank test were included in a secondary analysis using multivariate Cox proportional regression, variables with a value of p < 0.05 were considered statistically significant.
310 patients met the inclusion criteria. 89% underwent laparoscopic gastrectomy and 10.9% open gastrectomy. The resection margins were negative at 93.5% and the In terms of lymph node dissection, the median lymph nodes extracted was 20 (12;37), with statistically significant differences between the approaches in favor of the laparoscopic approach (Median 21 vs 12; z = - 2.19, p = 0.02). The survival rate was at 1, 3, and 5 years of 84.04%, 66.9%, and 65.47% respectively. The presence of complications and the ICU requirement have a negative impact on survival at 1 year (p 0.00).
A laparoscopic approach is safe with acceptable morbidity and mortality rates for treating gastric cancer. D2 Lymphadenectomy could be performed successfully in a laparoscopic approach in a high-volume center and a properly standardized technique. Major postoperative morbidity with intensive care unit requirement seems to influence overall survival rates.
根治性胃切除术一直是有治愈意图的胃癌的主要治疗方法。腹腔镜在进展期胃癌(AGC)中的安全性仍存在争议。在我们的机构中,腹腔镜胃切除术是最常进行的方法。
我们旨在描述一个高容量中心在哥伦比亚治疗 AGC 的经验,并分析开放和腹腔镜方法的短期结果和 1、3 和 5 年的总生存率。
对接受开放或腹腔镜胃切除术治疗进展期胃癌的患者进行了一项回顾性交叉研究。在淋巴结状态和手术方法方面,进行了 Will-Coxon Mann Whitney 检验。使用 Kaplan-Meier 方法进行总体生存分析,以评估 1、3 和 5 年的总体生存率。进行了初始对数秩检验,以检验手术变量与总体生存率之间的关系,统计值如果 p<0.20 则被接受。在对数秩检验中具有初始统计学关系的数据被纳入多变量 Cox 比例回归的二次分析,p<0.05 的变量被认为具有统计学意义。
符合纳入标准的患者有 310 例。89%接受了腹腔镜胃切除术,10.9%接受了开放胃切除术。93.5%的切缘为阴性,在淋巴结清扫方面,腹腔镜组的中位淋巴结检出数为 20(12;37),两种方法之间存在统计学显著差异(中位数 21 与 12;z=-2.19,p=0.02)。1、3 和 5 年的生存率分别为 84.04%、66.9%和 65.47%。并发症的发生和 ICU 需求对 1 年的生存率有负面影响(p<0.00)。
腹腔镜方法是安全的,具有可接受的发病率和死亡率,可用于治疗胃癌。在高容量中心,D2 淋巴结清扫术可以在腹腔镜下成功进行,并且需要适当的标准化技术。术后主要并发症和 ICU 需求似乎会影响总体生存率。